Cargando…
Interstitial lung disease after receiving the mRNA-based COVID-19 vaccine tozinameran
Tozinameran, a messenger ribonucleic acid (mRNA)-based coronavirus disease 19 (COVID-19) vaccine, has a favorable safety profile and is highly efficacious in preventing COVID-19. Adverse reactions such as pain at the vaccination site, fever, malaise, headache, rash, and anaphylaxis have been commonl...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858430/ https://www.ncbi.nlm.nih.gov/pubmed/35223425 http://dx.doi.org/10.1016/j.rmcr.2022.101618 |